Richard J Daly - Net Worth and Insider Trading
Richard J Daly Net Worth
The estimated net worth of Richard J Daly is at least $39,102 dollars as of 2024-05-11. Richard J Daly is the Director of Opiant Pharmaceuticals Inc and owns about 1,800 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $37,170. Richard J Daly is also the CEO of Seneca Biopharma Inc and owns about 194 shares of Seneca Biopharma Inc (SNCA) stock worth over $1,932. Details can be seen in Richard J Daly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard J Daly has not made any transactions after 2019-09-12 and currently still holds the listed stock(s).
Transaction Summary of Richard J Daly
Richard J Daly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard J Daly owns 5 companies in total, including Opiant Pharmaceuticals Inc (OPNT) , Catalyst Pharmaceuticals Inc (CPRX) , and Seneca Biopharma Inc (SNCA) among others .
Click here to see the complete history of Richard J Daly’s form 4 insider trades.
Insider Ownership Summary of Richard J Daly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2019-09-12 | director |
| CPRX | Catalyst Pharmaceuticals Inc | 2015-02-19 | director |
| SNCA | Seneca Biopharma Inc | 2017-11-07 | director & Chief Executive Officer |
 | | 2017-06-28 | director |
| | 2016-02-15 | director & CEO & President |
Richard J Daly Latest Holdings Summary
Richard J Daly currently owns a total of 2 stocks. Among these stocks, Richard J Daly owns 1,800 shares of Opiant Pharmaceuticals Inc (OPNT) as of September 12, 2019, with a value of $37,170 and a weighting of 95.06%. Richard J Daly also owns 194 shares of Seneca Biopharma Inc (SNCA) as of May 17, 2017, with a value of $1,932 and a weighting of 4.94%.
Latest Holdings of Richard J Daly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2019-09-12 | 1,800 | 20.65 | 37,170 |
| SNCA | Seneca Biopharma Inc | 2017-05-17 | 194 | 9.96 | 1,932 |
Holding Weightings of Richard J Daly
Richard J Daly Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard J Daly has made a total of 1 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the acquisition of 1,800 shares on September 12, 2019, which cost Richard J Daly around $25,020.
According to the SEC Form 4 filings, Richard J Daly has made a total of 0 transactions in Seneca Biopharma Inc (SNCA) over the past 5 years. The most-recent trade in Seneca Biopharma Inc is the acquisition of 63 shares on May 17, 2017, which cost Richard J Daly around $30,000.
Insider Trading History of Richard J Daly
- 1
Richard J Daly Trading Performance
GuruFocus tracks the stock performance after each of Richard J Daly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard J Daly is 2.24%. GuruFocus also compares Richard J Daly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard J Daly within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard J Daly's insider trading performs compared to the benchmark.
Performance of Richard J Daly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.69 | | | | | |
| Relative Return to S&P 500(%) | 7.63 | | | | | |
Richard J Daly Ownership Network
Richard J Daly Owned Company Details
What does Opiant Pharmaceuticals Inc do?
Who are the key executives at Opiant Pharmaceuticals Inc?
Richard J Daly is the director of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and director & 10 percent owner & Chief Executive Officer Roger Crystal .
Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary
Over the past 18 months, Richard J Daly made no insider transaction in Opiant Pharmaceuticals Inc (OPNT). Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .
In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.
Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Opiant Pharmaceuticals Inc Insider Transactions
Richard J Daly Mailing Address
Above is the net worth, insider trading, and ownership report for Richard J Daly. You might contact Richard J Daly via mailing address: 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
